Central Nervous System Tumor clinical trials at UC Davis
1 research study open to eligible people
A Study of Radiation Therapy With Temozolomide Versus Radiation Therapy With PCV Chemotherapy in Brain Tumors
open to eligible people ages 18 years and up
Radiation therapy uses high-energy x-rays to kill tumor cells. Drugs used in chemotherapy, such as temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. It is not yet known whether giving radiation with concomitant and adjuvant temozolomide versus radiation with adjuvant PCV is more effective in treating anaplastic glioma or low grade glioma.
Sacramento, California and other locations
Our lead scientists for Central Nervous System Tumor research studies include Orwa Aboud.